![Jay Backstrom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Backstrom
Director/Board Member at
AGIOS PHARMACEUTICALS, INC.
Net worth: 4 M $ as of 2026-06-29
Profile
Presently, Jay T. Backstrom occupies the position of Executive VP & Head-Research & Development at Acceleron Pharma, Inc. He is also on the board of Autolus Therapeutics Plc. In his past career he held the position of Medical Director of Samuel U. Rodgers Community Health Center, Inc., Chief Medical Officer for Celgene Corp., Executive Director-Medical & Scientific Services at Quintiles, Inc. (California) and Vice President-Global Medical & Safety at Pharmion Corp. He received a doctorate from Temple University School of Medicine and a graduate degree from St Louis University School of Public Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-03-25 | 76,277 ( 0.07% ) | 4 M $ | 2026-06-29 | |
| 2026-07-07 | 1,447 ( 0% ) | 53 698 $ | 2026-06-29 |
Jay Backstrom active positions
| Companies | Position | Start |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director/Board Member | 2025-07-07 |
Be Biopharma, Inc.
 Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Director/Board Member | 2021-12-15 |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Director/Board Member | 2021-11-30 |
Pancreatic Cancer Action Network, Inc.
 Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Director/Board Member | 2023-06-30 |
Former positions of Jay Backstrom
| Companies | Position | End |
|---|---|---|
| LAVA THERAPEUTICS | Director/Board Member | 2025-11-06 |
| SCHOLAR ROCK HOLDING CORPORATION | Chief Executive Officer | 2025-04-26 |
| DISC MEDICINE, INC. | Director/Board Member | 2023-06-08 |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 2023-02-27 |
| ACCELERON PHARMA INC. | Chief Tech/Sci/R&D Officer | 2021-11-30 |
Training of Jay Backstrom
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Samuel U. Rodgers Community Health Center, Inc.
 Samuel U. Rodgers Community Health Center, Inc. Samuel U. Rodgers Community Health Center, Inc. is a federally qualified nonprofit health organization dedicated to providing affordable healthcare to over 23,000 individuals annually. The private company is based in Kansas City, MO. Established in 1968, the center offers comprehensive services for all ages, including medical care, behavioral health counseling, dental and vision care, telehealth, and health insurance assistance. It provides integrated physical and mental health support, specialized programs for men’s health and maternal and infant health, and services accessible regardless of insurance status. The center is expanding its facilities to address primary care shortages and improve access for vulnerable children, and offers patient education resources, interpretation services in over 40 languages, and community partnerships to enhance care accessibility. | |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Health Services |
St Louis University School of Public Health
 St Louis University School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
LAVA Therapeutics NV
 LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Commercial Services |
Lewis Katz School of Medicine
 Lewis Katz School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Be Biopharma, Inc.
Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Health Technology |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
- Stock Market
- Insiders
- Jay Backstrom
